European Journal of Medicinal Chemistry p. 595 - 602 (1990)
Update date:2022-08-02
Topics:
Howson
Armstrong
Cassidy
Novelli
Tchorzewska
Jaxa-Chamiec
Dolle
Hallam
Leigh
Merritt
Moores
Rink
Receptor mediated calcium entry (RMCE) is a now recognised mechanism by which the influx of Ca2+ into cells can occur. Agents which antagonise or block this mechanism are expected to possess anti-platelet aggregation and anti-inflammatory activities. The first series of RMCE blockers based upon the lead compound SC 38249, has been prepared. Their synthesis, activity against ADP evoked Ca2+ signals in human platelets and their anti-platelet aggregation activity is described. A trend between the c log P of these compounds and their activity as inhibitors of Ca2+ influx into human platelets stimulated by ADP was observed. This SAR study led to a 40-fold increase in activity over the initial lead compound.
View MoreShanghai Kangxin Chemical Co., Ltd
Contact:+86 21 60717227
Address:118,Ganbai Village,Waigang Town,Jiading District,Shanghai
Zhejiang Chemicals Import & Export Corporation
Contact:86-571-87043088
Address:No.37,Qingchun Road,Hangzhou,China
Shao Xing Empire Import&Export CO.,ltd
Contact:86-575-82127757
Address:11#, Weiwu Road, Shangyu Industrial Park, Hangzhou Bay, Hangzhou, Zhejiang Province, China
Hubei Xinjing New Material Co.,Ltd
Contact:+86-27-83313147
Address:Room402.#Bthe 7th,Headquarter of Huifeng Corporation Qiaokou District,Wuhan China
Contact:+86-535-8888888
Address:No.161 Haishi Rd.
Doi:10.1016/S0040-4020(01)96012-0
(1990)Doi:10.1016/0022-328X(90)85478-H
(1990)Doi:10.1002/anie.201101524
(2011)Doi:10.1021/jo00172a056
(1983)Doi:10.1055/s-1990-27095
(1990)Doi:10.1016/S0040-4020(01)87896-0
(1990)